End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.43 EGP | -5.81% | -8.65% | -22.61% |
03-03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Sales 2024 * | 36.64B 768M 1.05B | Sales 2025 * | 44.09B 924M 1.26B | Capitalization | 2.45B 51.33M 70.1M |
---|---|---|---|---|---|
Net income 2024 * | 417M 8.74M 11.93M | Net income 2025 * | 417M 8.74M 11.93M | EV / Sales 2024 * | 0.17 x |
Net Debt 2024 * | 3.65B 76.46M 104M | Net Debt 2025 * | 3.56B 74.64M 102M | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
8.6
x | P/E ratio 2025 * |
6.7
x | Employees | 5,500 |
Yield 2024 * |
1.51% | Yield 2025 * |
3% | Free-Float | 61.4% |
1 day | -5.81% | ||
1 week | -8.65% | ||
Current month | +1.67% | ||
1 month | -10.00% | ||
3 months | -25.46% | ||
6 months | +8.48% | ||
Current year | -22.61% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-27 | 2.43 | -5.81% | 12 224 321 |
24-04-24 | 2.58 | -8.51% | 31,964,310 |
24-04-23 | 2.82 | -2.76% | 38,097,040 |
24-04-22 | 2.9 | +5.84% | 13,753,820 |
24-04-21 | 2.74 | +3.01% | 6,052,380 |
End-of-day quote Egyptian Exchange, April 27, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.61% | 54.3M | |
-32.21% | 15.27B | |
-31.97% | 10.84B | |
-30.42% | 6.06B | |
+8.14% | 6.04B | |
-11.41% | 5.86B | |
-1.17% | 4.71B | |
+52.19% | 4.29B | |
-14.86% | 3.33B | |
-6.93% | 3.01B |
- Stock Market
- Equities
- ISPH Stock